HEADER TRANSFERASE 02-SEP-15 5DJV
TITLE CRYSTAL STRUCTURE OF HUMAN FPPS IN COMPLEX WITH BIARYL COMPOUND 8E
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: FARNESYL PYROPHOSPHATE SYNTHASE;
COMPND 3 CHAIN: F;
COMPND 4 FRAGMENT: UNP RESIDUES 72-419;
COMPND 5 SYNONYM: FPS,(2E,6E)-FARNESYL DIPHOSPHATE SYNTHASE,
COMPND 6 DIMETHYLALLYLTRANSTRANSFERASE,FARNESYL DIPHOSPHATE SYNTHASE,
COMPND 7 GERANYLTRANSTRANSFERASE;
COMPND 8 EC: 2.5.1.10,2.5.1.1;
COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: FDPS, FPS, KIAA1293;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_VARIANT: TUNER;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28
KEYWDS TRANSFERASE, ISOPRENE BIOSYNTHESIS, CHOLESTEROL BIOSYNTHESIS
EXPDTA X-RAY DIFFRACTION
AUTHOR J.M.RONDEAU,E.BOURGIER,S.LEHMANN
REVDAT 3 08-MAY-24 5DJV 1 REMARK
REVDAT 2 04-NOV-15 5DJV 1 JRNL
REVDAT 1 07-OCT-15 5DJV 0
JRNL AUTH A.L.MARZINZIK,R.AMSTUTZ,G.BOLD,E.BOURGIER,S.COTESTA,
JRNL AUTH 2 J.F.GLICKMAN,M.GOTTE,C.HENRY,S.LEHMANN,J.C.HARTWIEG,S.OFNER,
JRNL AUTH 3 X.PELLE,T.P.RODDY,J.M.RONDEAU,F.STAUFFER,S.J.STOUT,A.WIDMER,
JRNL AUTH 4 J.ZIMMERMANN,T.ZOLLER,W.JAHNKE
JRNL TITL DISCOVERY OF NOVEL ALLOSTERIC NON-BISPHOSPHONATE INHIBITORS
JRNL TITL 2 OF FARNESYL PYROPHOSPHATE SYNTHASE BY INTEGRATED LEAD
JRNL TITL 3 FINDING.
JRNL REF CHEMMEDCHEM V. 10 1884 2015
JRNL REFN ESSN 1860-7187
JRNL PMID 26381451
JRNL DOI 10.1002/CMDC.201500338
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH W.JAHNKE,J.M.RONDEAU,S.COTESTA,A.MARZINZIK,X.PELLE,M.GEISER,
REMARK 1 AUTH 2 A.STRAUSS,M.GOTTE,F.BITSCH,R.HEMMIG,C.HENRY,S.LEHMANN,
REMARK 1 AUTH 3 J.F.GLICKMAN,T.P.RODDY,S.J.STOUT,J.R.GREEN
REMARK 1 TITL ALLOSTERIC NON-BISPHOSPHONATE FPPS INHIBITORS IDENTIFIED BY
REMARK 1 TITL 2 FRAGMENT-BASED DISCOVERY.
REMARK 1 REF NAT.CHEM.BIOL. V. 6 660 2010
REMARK 1 REFN ESSN 1552-4469
REMARK 1 PMID 20711197
REMARK 1 DOI 10.1038/NCHEMBIO.421
REMARK 1 REFERENCE 2
REMARK 1 AUTH W.JAHNKE,G.BOLD,A.MARZINZIK,S.OFNER,X.PELLE,S.COTESTA,
REMARK 1 AUTH 2 E.BOURGIER,S.LEHMANN,C.HENRY,R.HEMMIG,F.STAUFFER,
REMARK 1 AUTH 3 C.MUELLER-HARTWIEG,J.R.GREEN,J.M.RONDEAU
REMARK 1 TITL TUNING BONE AFFINITY INTO NON-BISPHOSPHONATE FPPS
REMARK 1 TITL 2 INHIBITORS: A GENERAL STRATEGY FOR TARGETING DRUGS ACTING ON
REMARK 1 TITL 3 BONE
REMARK 1 REF TO BE PUBLISHED
REMARK 1 REFN
REMARK 2
REMARK 2 RESOLUTION. 2.30 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.5
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.52
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9
REMARK 3 NUMBER OF REFLECTIONS : 21187
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.211
REMARK 3 R VALUE (WORKING SET) : 0.209
REMARK 3 FREE R VALUE : 0.242
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1059
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 11
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.41
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.91
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2795
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2342
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2656
REMARK 3 BIN R VALUE (WORKING SET) : 0.2337
REMARK 3 BIN FREE R VALUE : 0.2428
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.97
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 139
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2774
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 28
REMARK 3 SOLVENT ATOMS : 27
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 54.91
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 94.73
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 7.17560
REMARK 3 B22 (A**2) : 7.17560
REMARK 3 B33 (A**2) : -14.35120
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.468
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.256
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.201
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.257
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.204
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2865 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 3883 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1000 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 82 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 405 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2865 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 357 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 3363 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.01
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.57
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.58
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { F|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 10.1394 80.5855 26.3300
REMARK 3 T TENSOR
REMARK 3 T11: -0.3620 T22: -0.3761
REMARK 3 T33: 0.4614 T12: -0.0222
REMARK 3 T13: 0.0161 T23: 0.0642
REMARK 3 L TENSOR
REMARK 3 L11: 4.1868 L22: 2.6753
REMARK 3 L33: 1.9355 L12: 0.8928
REMARK 3 L13: -1.5909 L23: -0.5456
REMARK 3 S TENSOR
REMARK 3 S11: -0.1230 S12: -0.2930 S13: -0.7140
REMARK 3 S21: 0.0895 S22: 0.0465 S23: 0.2739
REMARK 3 S31: 0.2857 S32: -0.0334 S33: 0.0765
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5DJV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-SEP-15.
REMARK 100 THE DEPOSITION ID IS D_1000213318.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 14-DEC-05
REMARK 200 TEMPERATURE (KELVIN) : 88
REMARK 200 PH : 4.7
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X10SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97856
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS SEPTEMBER 26, 2012
REMARK 200 DATA SCALING SOFTWARE : XSCALE NOVEMBER 3, 2014
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21202
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300
REMARK 200 RESOLUTION RANGE LOW (A) : NULL
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : 0.06900
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.8000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7
REMARK 200 DATA REDUNDANCY IN SHELL : 7.16
REMARK 200 R MERGE FOR SHELL (I) : 1.42100
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.800
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: CNX 2005
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 57.40
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2M SODIUM POTASSIUM PHOSPHATE, 25%
REMARK 280 GLYCEROL, PH 4.7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.01000
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.94000
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.94000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.50500
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.94000
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.94000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.51500
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.94000
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.94000
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 18.50500
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.94000
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.94000
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 55.51500
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 37.01000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 4020 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 29830 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: F
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 111.88000
REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 111.88000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 37.01000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY F 4
REMARK 465 PRO F 5
REMARK 465 ASN F 6
REMARK 465 SER F 7
REMARK 465 ARG F 351
REMARK 465 ARG F 352
REMARK 465 LYS F 353
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 VAL F 124 -70.19 -88.56
REMARK 500 THR F 201 -57.91 -120.26
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 5BL F 401
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 5DGN RELATED DB: PDB
REMARK 900 HUMAN FPPS COMPLEX WITH BIARYL COMPOUND 8A
REMARK 900 RELATED ID: 5DIQ RELATED DB: PDB
REMARK 900 HUMAN FPPS COMPLEX WITH SALICYLIC ACID DERIVATIVE 3A
REMARK 900 RELATED ID: 5DJP RELATED DB: PDB
REMARK 900 HUMAN FPPS COMPLEX WITH BIARYL COMPOUND 5
REMARK 900 RELATED ID: 5DJR RELATED DB: PDB
REMARK 900 HUMAN FPPS COMPLEX WITH BIARYL COMPOUND 6
DBREF 5DJV F 6 353 UNP P14324 FPPS_HUMAN 72 419
SEQADV 5DJV GLY F 4 UNP P14324 EXPRESSION TAG
SEQADV 5DJV PRO F 5 UNP P14324 EXPRESSION TAG
SEQRES 1 F 350 GLY PRO ASN SER ASP VAL TYR ALA GLN GLU LYS GLN ASP
SEQRES 2 F 350 PHE VAL GLN HIS PHE SER GLN ILE VAL ARG VAL LEU THR
SEQRES 3 F 350 GLU ASP GLU MET GLY HIS PRO GLU ILE GLY ASP ALA ILE
SEQRES 4 F 350 ALA ARG LEU LYS GLU VAL LEU GLU TYR ASN ALA ILE GLY
SEQRES 5 F 350 GLY LYS TYR ASN ARG GLY LEU THR VAL VAL VAL ALA PHE
SEQRES 6 F 350 ARG GLU LEU VAL GLU PRO ARG LYS GLN ASP ALA ASP SER
SEQRES 7 F 350 LEU GLN ARG ALA TRP THR VAL GLY TRP CYS VAL GLU LEU
SEQRES 8 F 350 LEU GLN ALA PHE PHE LEU VAL ALA ASP ASP ILE MET ASP
SEQRES 9 F 350 SER SER LEU THR ARG ARG GLY GLN ILE CYS TRP TYR GLN
SEQRES 10 F 350 LYS PRO GLY VAL GLY LEU ASP ALA ILE ASN ASP ALA ASN
SEQRES 11 F 350 LEU LEU GLU ALA CYS ILE TYR ARG LEU LEU LYS LEU TYR
SEQRES 12 F 350 CYS ARG GLU GLN PRO TYR TYR LEU ASN LEU ILE GLU LEU
SEQRES 13 F 350 PHE LEU GLN SER SER TYR GLN THR GLU ILE GLY GLN THR
SEQRES 14 F 350 LEU ASP LEU LEU THR ALA PRO GLN GLY ASN VAL ASP LEU
SEQRES 15 F 350 VAL ARG PHE THR GLU LYS ARG TYR LYS SER ILE VAL LYS
SEQRES 16 F 350 TYR LYS THR ALA PHE TYR SER PHE TYR LEU PRO ILE ALA
SEQRES 17 F 350 ALA ALA MET TYR MET ALA GLY ILE ASP GLY GLU LYS GLU
SEQRES 18 F 350 HIS ALA ASN ALA LYS LYS ILE LEU LEU GLU MET GLY GLU
SEQRES 19 F 350 PHE PHE GLN ILE GLN ASP ASP TYR LEU ASP LEU PHE GLY
SEQRES 20 F 350 ASP PRO SER VAL THR GLY LYS ILE GLY THR ASP ILE GLN
SEQRES 21 F 350 ASP ASN LYS CYS SER TRP LEU VAL VAL GLN CYS LEU GLN
SEQRES 22 F 350 ARG ALA THR PRO GLU GLN TYR GLN ILE LEU LYS GLU ASN
SEQRES 23 F 350 TYR GLY GLN LYS GLU ALA GLU LYS VAL ALA ARG VAL LYS
SEQRES 24 F 350 ALA LEU TYR GLU GLU LEU ASP LEU PRO ALA VAL PHE LEU
SEQRES 25 F 350 GLN TYR GLU GLU ASP SER TYR SER HIS ILE MET ALA LEU
SEQRES 26 F 350 ILE GLU GLN TYR ALA ALA PRO LEU PRO PRO ALA VAL PHE
SEQRES 27 F 350 LEU GLY LEU ALA ARG LYS ILE TYR LYS ARG ARG LYS
HET 5BL F 401 28
HETNAM 5BL 8-(NAPHTHALEN-1-YL)-6-(1H-PYRROL-2-YL)QUINOLINE-2-
HETNAM 2 5BL CARBOXYLIC ACID
FORMUL 2 5BL C24 H16 N2 O2
FORMUL 3 HOH *27(H2 O)
HELIX 1 AA1 ASP F 8 HIS F 20 1 13
HELIX 2 AA2 HIS F 20 THR F 29 1 10
HELIX 3 AA3 GLU F 30 MET F 33 5 4
HELIX 4 AA4 HIS F 35 GLU F 37 5 3
HELIX 5 AA5 ILE F 38 ALA F 53 1 16
HELIX 6 AA6 TYR F 58 VAL F 72 1 15
HELIX 7 AA7 GLU F 73 GLN F 77 5 5
HELIX 8 AA8 ASP F 78 ASP F 107 1 30
HELIX 9 AA9 TRP F 118 LYS F 121 5 4
HELIX 10 AB1 VAL F 124 LEU F 126 5 3
HELIX 11 AB2 ASP F 127 ARG F 148 1 22
HELIX 12 AB3 TYR F 152 ALA F 178 1 27
HELIX 13 AB4 THR F 189 THR F 201 1 13
HELIX 14 AB5 THR F 201 PHE F 206 1 6
HELIX 15 AB6 PHE F 206 ALA F 217 1 12
HELIX 16 AB7 GLY F 221 GLY F 250 1 30
HELIX 17 AB8 ASP F 251 GLY F 256 1 6
HELIX 18 AB9 SER F 268 ARG F 277 1 10
HELIX 19 AC1 THR F 279 TYR F 290 1 12
HELIX 20 AC2 GLU F 294 LEU F 308 1 15
HELIX 21 AC3 ASP F 309 ALA F 333 1 25
HELIX 22 AC4 PRO F 338 TYR F 349 1 12
SHEET 1 AA1 2 THR F 111 ARG F 112 0
SHEET 2 AA1 2 GLN F 115 ILE F 116 -1 O GLN F 115 N ARG F 112
CISPEP 1 ALA F 334 PRO F 335 0 11.11
SITE 1 AC1 12 TYR F 10 LYS F 57 TYR F 58 ASN F 59
SITE 2 AC1 12 ARG F 60 SER F 205 PHE F 239 GLN F 242
SITE 3 AC1 12 LEU F 344 LYS F 347 ILE F 348 HOH F 514
CRYST1 111.880 111.880 74.020 90.00 90.00 90.00 P 41 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008938 0.000000 0.000000 0.00000
SCALE2 0.000000 0.008938 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013510 0.00000